None listed
Conditions
Interventions
None listed
Sponsors
Seoul National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients over 19 years of age (2) Patients who need total mastectomy for breast cancer (3) Patients undergoing immediate two-stage implant breast reconstruction after total mastectomy (skin preservation) is performed. (4) Patients who use Acelluar Dermal Matrix for breast reconstruction (5) Patients who need radiotherapy after breast reconstruction (6) Patients who agree to participate in the study and can be followed up within the study period
Exclusion criteria
Exclusion criteria: (1) A patient undergoing chemotherapy for cancer other than breast cancer (2) Patients with confirmed local recurrence or systemic metastasis of breast cancer (3) Patients with underlying conditions such as infectious diseases, systemic autoimmune diseases (especially rheumatoid diseases, etc.), and blood coagulation disorders (4) Patients with systemic diseases other than breast cancer (5) Pregnant women or lactating women (6) Other patients who were judged to be difficult to participate in this study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| tissue engraft evaluation;Evaluation of the effectiveness of capsule formation | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction evaluation;Complications evaluation | — |
Countries
Korea, Republic of
Contacts
Public ContactUng Sik Jin
Seoul National University Hospital
Outcome results
None listed